US Market Overview for Hearing Aids and Audiology Devices 2017 – MedView

US Market Overview for Hearing Aids and Audiology Devices 2017 – MedView

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 11/1/16
  • Pages: 57
  • Type: MedView

The U.S. market for hearings aids and audiology devices includes traditional hearing aids, bone-anchored hearing aids, cochlear implants, middle ear implants, otoacoustic emission (OAE) analyzers, auditory brainstem response (ABR) analyzers, audiometers, tympanometers, real ear analyzers, otoscopes and personal sounds amplification products (PSAPs). The hearing aid and audiology device market in the U.S. includes a wide array of devices designed to diagnose and treat hearing loss. Approximately 40 million people in the U.S. suffered from hearing impairment in 2016; however, only a minor portion of this population purchased hearing aids as a treatment that year. This market remains at only a fraction of its potential size as increasing device penetration remained challenging. The hearing aid and audiology device market comprises both standard and implantable hearing aids as well as diagnostic equipment, which consists of otoscopes and equipment designed to detect hearing loss.

The traditional hearing aid market in this report is analyzed at both a manufacturer level, as well as at a retail level. The manufacturer hearing aid market segment represents the revenue generated from manufacturers selling their hearing aids to retailers. The retail hearing aid market segment represents the revenue generated from retailers selling hearing aids to end users. This approach was taken in order to do a comparison of the market revenue of the manufacturers of the hearing aid devices versus the retail hearing aid sales. In most states, the right to sell hearing aids is limited to audiologists and hearing instrument specialists. Audiologists require several years of schooling and, in most states, hearing instrument specialists are required to take a two year course in hearing loss diagnosis and hearing aid fitting before they are certified to sell. These requirements limit the number and growth rate of points of sale, in turn limiting the overall growth potential of the hearing aid market. Any measures to broaden distribution channels in a way that do not alienate audiologists and independent hearing instrument specialists will enhance hearing aid sales. One major driver is the aging population. As a person ages, the rate occurrence of hearing impairment increases. In the United States, the baby boomer demographic (those born between 1945 and 1965, colloquially) is entering ages where hearing impairment increases. As such, the customer base will continue to expand. If these new candidates can be successfully targeted, there is a large potential for growth.



The "US Market Report Suite for Hearing Aids and Audiology Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Phonak
Starkey
Cochlear
Oticon
Sivantos
Rayovac
GN ReSound
MED-EL
Widex
VARTA
Unitron
Advanced Bionics
Duracell
Sophono
ZeniPower
Energizer
Maico
Grason-Stadler
Interacoustics
MedRx
Natus
Audioscan
GN Otometrics
Benson Medical Instruments
Intelligent Hearing Systems
Tremetrics
Welch Allyn
Frye Electronics
Ambco
Envoy Medical
Ototronix
Heine
Others include: Advanced Monitors Corporation, Ambco, American Diagnostics, Amplivox, Audina, Audioscan, Auditdata, Benson Medical Instruments, Duracell, e3 Audiometrics, Foster Special Instruments, Frye Electronics, GlobalMed Telemedicine, GN Otometrics, Grason-Stadler, Hansaton, Hear Clear, Heine, iCellTech, Intelligent Hearing Systems, Interacoustics, Inventis, KaWe, Madsen, Maico, MEDca, MedRx, Micro Audiometrics Corp, MicroTech, Natus, NEXcell, Otovation, Panasonic, Path Medical, Persona Medical, Renata, Riester, Rion, SeboTek Hearing Systems, Songbird Hearing, Sony, SoundHawk, Toshiba, Tremetrics, US Ophthalmic, Vivosonic, Welch Allyn, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×